• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Authors


Rozalina G. McCoy, MD, MS

Latest:

Patient Attribution: Why the Method Matters

Reliable identification of the physician–patient relationship is necessary for accurate evaluation. Standardization of evidence-based attribution methods is essential to improve the value of healthcare.


Yonghua Jing, PhD

Latest:

Impact of Cost-Sharing on Treatment Augmentation in Patients With Depression

Higher patient cost-sharing is associated with a lower likelihood of treatment augmentation in patients with depression who are treated with antidepressants.


Bruce Feinberg, DO

Latest:

Better Together? Costs of First-line Chemoimmunotherapy for Advanced Non–Small Cell Lung Cancer

Compared with first-line immunotherapy or chemotherapy alone, combination chemoimmunotherapy for advanced/metastatic non–small cell lung cancer has significantly higher antineoplastic drug and associated medical costs.


William S. Weintraub, MD

Latest:

Impact of Care Coordination Based on Insurance and Zip Code

A care transitions program for patients who underwent percutaneous coronary intervention appeared to reduce 30-day rehospitalizations for patients with Medicaid who lived in wealthier zip codes.




Stuart C. Gordon, MD

Latest:

Late Diagnosis of Hepatitis C Virus Infection, 2014-2016: Continuing Missed Intervention Opportunities

Late hepatitis C virus infection diagnosis points to a need for earlier screening and treatment before the onset of severe liver disease leading to high cost and diminished outcomes.



Bevanne Bean-Mayberry, MD, MHS

Latest:

Organization of Care and Diagnosed Depression Among Women Veterans

This analysis studies effects of practice structures, primary care and mental health integration, and sex-specific primary care services on diagnosis of depression among women veterans.


Pamela Roberto, PhD

Latest:

Impact of Formulary Restrictions on Medication Intensification in Diabetes Treatment

Formulary restrictions on brand name noninsulin antihyperglycemic drugs have little impact on treatment intensification patterns among low-income patients with diabetes in Medicare Part D.



Andrea Hassol, MSPH

Latest:

Enhancing Patient and Family Engagement Through Meaningful Use Stage 3: Opportunities and Barriers to Implementation

Two leading US health systems attempted to implement 4 draft objectives for Meaningful Use Stage 3 within their health IT infrastructure to provide feedback on needed enhancements to the policy.


Judith Kutzleb, DNP

Latest:

Study: Health Recovery Solutions Uses Tablets to Reduce Cardiac Readmissions

Pilot program implemented at Hackensack ACO that provides hospitals and ACOs an early warning system to manage their highest risk patients.


Daniel A. Handel, MD, MBA, MPH

Latest:

Inpatient Placement: Associations With Mortality, Cost, and Length of Stay

Placement of patients in an inpatient hospital setting is associated with lower length of stay and mortality at the expense of higher costs.





Melinda B. Buntin, PhD

Latest:

Risk Adjusting for Medicaid Participation in Medicare Advantage

When comparing risk-adjustment approaches based on Medicaid status of Medicare beneficiaries, this analysis found that predicted spending levels varied depending on states’ Medicaid eligibility criteria.



Allison B. Rosen, MD, MPH, ScD

Latest:

Patient Adherence: A Blind Spot in Cost-Effectiveness Analyses?

A systematic literature review from 1998 to 2003 showed that few cost-effectiveness analyses of self-administered medications model suboptimal medication adherence.





Jill Mesa

Latest:

A Randomized, Pragmatic, Pharmacist-Led Intervention Reduced Opioids Following Orthopedic Surgery

This pharmacist-led, patient-directed intervention demonstrated a reduction in opioid dispensings in the 90 days following hip replacement but not knee replacement.


Lisa C. Richardson, MD, MPH

Latest:

Visit Duration for Outpatient Physician Office Visits Among Patients With Cancer

Higher use of performance-based payment mechanisms and capitated arrangements is associated with a decrease in the amount of time physicians spend with patients with cancer.


Bernard J. Gersh, MBChB, DPhil

Latest:

Clinical and Economic Outcomes After Introduction of Drug-Eluting Stents

Introduction of drug-eluting stents resulted in improved clinical outcomes for patients and reduced overall procedural costs.





Emily Meredith Gillen, PhD

Latest:

The Effect of Narrow Network Plans on Out-of-Pocket Cost

The authors examined the effect of narrow network plan selection on beneficiaries’ outpatient visits and outpatient out-of-pocket expenditures in the 2014 nongroup health insurance market.

© 2024 MJH Life Sciences
AJMC®
All rights reserved.